Mary Talley Bowden MD
@MdBreathe
·
239d
The statement is critical of the FDA and suggests a conflict of interest that may affect its decisions on medical treatments. It raises concerns about the potential influence of pharmaceutical funding on regulatory decisions, which is a matter of public interest and policy.
- The statement implies harm by suggesting that the FDA's decisions may not be in the public's best interest due to alleged bias. However, it does not provide evidence for its claims, which could be misleading or harmful if not substantiated. [-1]Principle 1:I will strive to do no harm with my words and actions.
- The statement respects the privacy and dignity of others as it does not target individuals but rather addresses an institution's policies.Principle 2:I will respect the privacy and dignity of others and will not engage in cyberbullying, harassment, or hate speech.
- The statement aims to promote understanding of a potential issue within a regulatory body, but it may lack empathy towards the complexities of drug regulation and the FDA's role in protecting public health. [-1]Principle 4:I will engage in constructive criticism and dialogue with those in disagreement and will not engage in personal attacks or ad hominem arguments.
- The statement uses its influence to question the integrity of the FDA, which could be seen as promoting a betterment of society if it leads to increased transparency and accountability. However, without evidence, it could also lead to public distrust in regulatory bodies.Principle 6:I will use my influence for the betterment of society.
- The statement upholds the principles of free speech by expressing a viewpoint on a public matter, but it may lack integrity if the insinuations are unfounded. [-1]Principle 7:I will uphold the principles of free speech and use my platform responsibly and with integrity.